{"id":131057,"date":"2025-11-13T12:44:11","date_gmt":"2025-11-13T12:44:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/131057\/"},"modified":"2025-11-13T12:44:11","modified_gmt":"2025-11-13T12:44:11","slug":"weightwatchers-announces-plans-to-sell-wegovy-pill","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/131057\/","title":{"rendered":"WeightWatchers announces plans to sell Wegovy pill"},"content":{"rendered":"

Your support helps us to tell the story<\/p>\n

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it’s investigating the financials of Elon Musk’s pro-Trump PAC or producing our latest documentary, ‘The A Word’, which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.<\/p>\n

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.<\/p>\n

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.<\/p>\n

Your support makes all the difference.Read more<\/p>\n

WeightWatchers <\/a>has announced its plans<\/a> to sell Novo Nordisk<\/a>‘s highly anticipated Wegovy<\/a> in pill form<\/a>, should it launch in the U.S. next year, further cementing its partnership with the Danish pharmaceutical giant.<\/p>\n

This strategic move could provide a significant boost for WeightWatchers as it navigates its emergence from bankruptcy, underscoring its commitment to offering branded obesity medications \u2014 in ontrast to competitors who often promote more affordable generic alternatives in a fiercely competitive market.<\/p>\n

Tara Comonte, WeightWatchers CEO, confirmed the collaboration, stating: \u201cWe have been working with Novo Nordisk ahead of time to support the launch of oral weight-loss medication.\u201d <\/p>\n

She further highlighted the appeal of the new format, adding, \u201cA lot of people don’t want an injection. And the convenience of a pill is going to be huge.\u201d<\/p>\n

The development comes as weight loss pills from both Novo Nordisk and rival Eli Lilly<\/a> are under consideration for an expedited U.S. review process, potentially fast-tracking their market availability.<\/p>\n

\"WeightWatchersWeightWatchers is also trying to gain a stronger foothold in women’s health, including through tailored programs that offer GLP-1 medicines and hormone replacement therapy. (Sundry Photography – stock.adobe.com)<\/p>\n

WeightWatchers could keep more customers on its platform than telehealth rivals, as doctors expect U.S. patients to switch to the branded medicines once prices come down under a deal announced last week by the White House.<\/p>\n

Lilly and Novo agreed to slash prices of their popular GLP-1 injectable drugs for U.S. government health programs and cash-paying customers.<\/p>\n

Starter doses of the weight-loss pills, if approved, will cost $149 a month for Medicare and Medicaid enrollees and for cash payers through the U.S. administration’s new TrumpRx site.<\/p>\n

“Anything that brings pricing down for these medications is good for WeightWatchers,” Comonte said.<\/p>\n

WeightWatchers is also trying to gain a stronger foothold in women’s health, including through tailored programs that offer GLP-1 medicines and hormone replacement therapy.<\/p>\n

Outside of the U.S., Germany and the UK are major markets for WeightWatchers, which had 4 million subscribers worldwide at the end of 2023.<\/p>\n","protected":false},"excerpt":{"rendered":"Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…\n","protected":false},"author":2,"featured_media":131058,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[163,85,46,482],"class_list":{"0":"post-131057","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-il","10":"tag-israel","11":"tag-medication"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/131057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=131057"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/131057\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/131058"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=131057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=131057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=131057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}